Page last updated: 2024-11-01

ofloxacin and Male Genitourinary Diseases

ofloxacin has been researched along with Male Genitourinary Diseases in 5 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research Excerpts

ExcerptRelevanceReference
"Ofloxacin therapy was administered an average of 45 days per patient, and was well tolerated."2.67Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents. ( Eron, LJ; Gentry, LO, 1992)
"Levofloxacin has a tolerability profile similar to that of other oral fluoroquinolones, with gastrointestinal and central nervous system effects reported most commonly."2.39Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. ( Bryson, HM; Davis, R, 1994)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marone, P1
Concia, E1
Quarta, V1
Minoli, L1
Carnevale, G1
Davis, R1
Bryson, HM1
Kuznetsov, VP1
Dubenskiĭ, VV1
Delektorskiĭ, VV1
Igoshin, IuM1
Beliaev, DL1
Iashkova, GN1
Babaiants, AA1
D'Antonio, D1
Pizzigallo, E1
Iacone, A1
Dell'Isola, M1
Fioritoni, G1
Betti, S1
Piergallini, A1
Di Gianfilippo, R1
Olioso, P1
Torlontano, G1
Eron, LJ1
Gentry, LO1

Reviews

1 review available for ofloxacin and Male Genitourinary Diseases

ArticleYear
Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.
    Drugs, 1994, Volume: 47, Issue:4

    Topics: Administration, Oral; Aging; Bacteria; Bacterial Infections; Biological Availability; Drug Interacti

1994

Trials

1 trial available for ofloxacin and Male Genitourinary Diseases

ArticleYear
Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.
    Diagnostic microbiology and infectious disease, 1992, Volume: 15, Issue:5

    Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Diabetes Complications; Drug Resistance, Mi

1992

Other Studies

3 other studies available for ofloxacin and Male Genitourinary Diseases

ArticleYear
Ofloxacin in the treatment of genito-urinary tract infections.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Female Urogenital Disea

1989
[The combined therapy of patients with gonorrheal-chlamydial urogenital infections by leukinferon immunocorrection].
    Terapevticheskii arkhiv, 1993, Volume: 65, Issue:11

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Chlamydia Infections; Cytokines; Doxycycline; Drug Combin

1993
Occurrence of bacteremia in hematologic patients.
    European journal of epidemiology, 1992, Volume: 8, Issue:5

    Topics: Adolescent; Adult; Aged; Bacteremia; Bone Marrow Transplantation; Catheterization; Ciprofloxacin; Fe

1992